|
TeraView Ltd, the world leader in
commercial exploitation of Terahertz technology, is delighted
to announce that Michael Pepper, Chief Scientific Officer
and Co-Founder at TeraView Ltd, and Professor of Physics
at the University of Cambridge, has been knighted in
the New Year's Honours list.
As part of the continued strengthening
of its senior management team, the Company is also pleased
to announce that Paddy O'Kelly will join TeraView in
February 2006 as Chief Operating Officer.
TeraView Ltd. was founded by Professor
Michael Pepper and Dr Don Arnone in April 2001 as an
independent spin off from Toshiba Research Europe Ltd.
Professor Pepper is a pioneer of both semiconductor nanostructures
as well as Terahertz technology. He is a Fellow of the
Royal Society and of Trinity College, Cambridge.
Terahertz is a non-destructive imaging
tool using frequencies between the infrared and microwave
that were previously inaccessible. Under Professor Pepper's
guidance, the Company has successfully developed and
sold early stage products to major pharmaceutical companies
to aid in the design of new controlled release tablets,
as well as trouble shooting and quality control in pharmaceutical
manufacturing. The technology also has uses in non-intrusive
detection of non-metallic weapons and plastic explosives,
where product development is currently supported by the
US government, as well as the detection of cancer, where
early stage imaging prototypes are currently supported
by the National Health Service.
" Our team has worked with great
inventiveness and initiative to bring this technology
to its present powerful state. As little as three years
ago the technology was confined to the laboratory, and
they have transformed it into products used by customers
to solve previously intractable problems. Continual improvements,
including reduction in size and cost to open up new markets,
are the hallmarks of TeraView" says Professor Pepper.
Paddy O'Kelly joins TeraView as Chief
Operating Officer at a time when several large contracts
have been secured from major pharmaceutical customers
as well as medical imaging partners. Padraig brings over
20 years experience to operations and product development
as well as other commercial aspects of TeraView's business,
most recently from Applied Imaging Corporation where
he is Managing Director. "I am delighted to be joining
the Company at a time when it is facing a number of key
challenges related to its recent commercial successes",
said Paddy.
Dr Don Arnone, Chief Executive Officer
of TeraView Ltd, said "Having had the pleasure of
working both for and with Sir Michael in different capacities
over the last 13 years, I am personally delighted that
his numerous contributions to British science and industry
have been recognized in this manner. I join our Board,
shareholders and staff in extending congratulations to
Mike. I am also delighted that Paddy has chosen to join
TeraView, which is a testament to the Company's continuing
success in building up a world-class executive management
team. Given the recent contracts that we have successfully
procured from pharmaceutical and medical customers, it
is critical that we execute and deliver in a timely fashion,
and Paddy's breadth and depth of experience are vital
in this respect."
TeraView based in Cambridge, UK,
was spun-out of Toshiba Cambridge Research Laboratory
in April 2001 to commercially exploit the intellectual
property rights and expertise developed in the creation
and detection of Terahertz (THz) radiation using innovative
semiconductor technologies. Its founders are Dr Don Arnone,
previously Terahertz Programme Director at Toshiba and
Professor Michael Pepper who is Head of the Semiconductor
Physics Group at the University's Cavendish Laboratory.
The Company provides Terahertz spectrometer
(TPI spectra 1000) products for polymorph detection in
drug formulation and pharmaceutical R&D, as well
as tablet imaging products (TPI coating scan) to non-destructively
examine the 3D structural and chemical matrix and related
critical quality attributes of solid dosage forms for
product development as well as root cause analysis in
manufacture.
In addition to pharmaceutical applications,
the Company also works with end-users in the security
screening and medical imaging markets.
For further information please contact:
Dr Don Arnone
Chief Executive Officer
TeraView Ltd
Platinum Building
St John’s Innovation Centre
Cambridge CB4 0WG United Kingdom
Tel: +44 1223 435383
don.arnone@teraview.com
Prof Michael Pepper, FRS
Chief Scientific Officer
TeraView Ltd
Platinum Building
St John’s Innovation Centre
Cambridge CB4 0WG United Kingdom
Tel: +44 1223 435383
michael.pepper@teraview.com
|
